Kaul, Neha
Nicolo, John-Paul
O’Brien, Terence J.
Kwan, Patrick
Article History
Received: 22 June 2021
Accepted: 30 June 2021
First Online: 30 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: NK and J-PN declare no competing interests. PK is supported by a Medical Research Future Fund Fellowship (MRF1136427). He/his institution has received speaker or consultancy fees and/or research grants from Biscayne, Eisai, GW Pharmaceuticals, LivaNova, Novartis, UCB Pharma and Zynerba. TOB’s institution has received research grant funding from the Australian Government NHMRC and the US Government NINDS, and commercial clinical trial and research funding from Eisai, UCB, Zynerba, Anavex and Biogen Pharma. Author TOB and PK are the member of the Editorial Board for Acta Epileptologica, who were not involved in the journal's review of, or decisions related to this manuscript.